Doctor profile · Federal record

Dr. Sheryl Mulder, ARNP MSN FNPC

Nurse Practitioner · Registered Nurse · Family Nurse Practitioner · Ottumwa, IA

  • NPI 1962497438
  • Accepts Medicare
  • MIPS 83.3 / 100 · 2023
  • 28 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1005 Pennsylvania Ave, Suite 210
Ottumwa, IA 525016413
(641) 683-3195
fax (641) 683-3197
Mailing address
801 York St
Manitowoc, WI 542204630

Credentials & registration

NPPES · NUCC
NPI registered
September 2005 — 21 yrs on file
Profile last updated
February 23, 2021
Year of graduation
1998 — 28 yrs since
Specialty taxonomy
363L00000X — NUCC code
State licenses (2)
Iowa #A074290 · Iowa #074290

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1962497438. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
13,398
Distinct HCPCS
10
Medicare allowed
$201,028
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 10,200 43 $2
99213 Established patient office or other outpatient visit, 20-29 minutes 952 757 $72
17003 Destruction of precancer skin growth, 2-14 growths 555 150 $5
17110 Destruction of skin growth, 1-14 growths 501 409 $89
17000 Destruction of precancer skin growth, 1 growth 304 250 $37
11102 Biopsy of related skin growth, first growth 295 268 $65
99212 Established patient office or other outpatient visit, 10-19 minutes 231 160 $45
99203 New patient office or other outpatient visit, 30-44 minutes 109 109 $89
96372 Injection of drug or substance under skin or into muscle 68 15 $11
96573 Application of light by qualified health care professional to destroy precancer skin growth 47 42 $182

In context: peer comparison

Among 6 peers in Ottumwa Nurse Practitioner, average services per provider: 486. This provider delivers 28× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,732
Transactions
57
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Galderma Laboratories, L.P. 8 $473.70
Abbvie INC. 13 $176.68
Janssen Biotech, INC. 6 $173.45
Leo Pharma INC. 1 $142.34
Ucb, INC. 6 $141.48
E.R. Squibb & Sons, L.L.C. 7 $131.21
Sun Pharmaceutical Industries INC. 2 $106.72
Lilly USA, LLC 4 $80.01
Ortho Dermatologics, A Division of Bausch Health US, LLC 1 $66.93
Pfizer INC. 4 $63.58
Boehringer Ingelheim Pharmaceuticals, INC. 1 $27.56
Regeneron Healthcare Solutions, INC. 1 $24.28
Genzyme Corporation 1 $23.15
ConvaTec INC. 1 $20.16
Amgen INC. 1 $19.61

By nature of payment

Food and Beverage
$1,213
Travel and Lodging
$320
Education
$199

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
799
Patients
440
Total drug cost
$24,000
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 250 178 $2,256
Ketoconazole Generic 108 53 $3,003
Fluocinonide Generic 93 52 $5,452
Doxycycline Monohydrate Generic 58 21 $1,644
Prednisone Generic 46 40 $186
Valacyclovir (Valacyclovir Hcl) Brand 41 26 $1,026
Metronidazole Generic 37 21 $3,872
Mupirocin Generic 26 20 $269
Nystatin Generic 23 16 $319
Pentoxifylline Generic 23 0 $332

Frequently asked questions

Auto-generated from federal data
What is Dr. Sheryl Mulder's medical specialty?
Dr. Sheryl Mulder practices Nurse Practitioner in Ottumwa, IA.
Where does Dr. Sheryl Mulder practice?
Dr. Sheryl Mulder practices at 1005 Pennsylvania Ave, Ottumwa, IA 525016413. Office phone: 6416833195.
What is Dr. Sheryl Mulder's NPI?
Dr. Sheryl Mulder's National Provider Identifier (NPI) is 1962497438, issued by NPPES.
Does Dr. Sheryl Mulder accept Medicare assignment?
Yes. Dr. Sheryl Mulder accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sheryl Mulder commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003). Source: CMS Medicare Physician & Other Practitioners file.